SCHEMBL4017835

SCHEMBL4017835

CCCCCN1C(=O)[C@]2(COc3cc(Oc4ccccc4)ccc32)c2ccccc21

nearest known ligand 0.82

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 20/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL280687 1.00 SCN9A (0.82) SCN9A
SCHEMBL280870 0.92 SCN9A (0.70) SCN9A
SCHEMBL280921 0.90 SCN9A (1.00) SCN9A
SCHEMBL280713 0.84 SCN9A (0.76) SCN9A
SCHEMBL281015 0.84 SCN9A (0.75) SCN9A
SCHEMBL280748 0.84 SCN9A (0.75) SCN9A
SCHEMBL19562373 0.83 SCN9A (0.70) SCN9A
SCHEMBL280988 0.83 SCN9A (0.70) SCN9A
SCHEMBL19562377 0.82 SCN9A (0.72) SCN9A
SCHEMBL328323 0.82 SCN9A (0.69) SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2073806-A2 USE OF SPIRO-OXINDOLE COMPOUNDS AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2009-07-01 EP disclosed
WO-2008060789-A2 USE OF SPIRO-OXINDOLE COMPOUNDS AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2008-05-22 WO disclosed